A water-compatible magnetic molecularly imprinted polymer for the selective extraction of risperidone and 9-hydroxyrisperidone from human urine
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21372147, 81603286)
- Key Science and Technology Program of Shandong (2016GSF202033)
This publication has 42 references indexed in Scilit:
- Controlled synthesis of water-compatible molecularly imprinted polymer microspheres with ultrathin hydrophilic polymer shells via surface-initiated reversible addition-fragmentation chain transfer polymerizationSoft Matter, 2011
- Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UVJournal of Chromatography B, 2011
- Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedureTalanta, 2010
- Novel surface modified molecularly imprinted polymer using acryloyl-β-cyclodextrin and acrylamide as monomers for selective recognition of lysozyme in aqueous solutionJournal of Chromatography A, 2009
- Exploiting β-cyclodextrin as functional monomer in molecular imprinting for achieving recognition in aqueous mediaMaterials Science and Engineering: C, 2008
- Validated LC–MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urineJournal of Chromatography B, 2008
- Molecularly imprinted polymer prepared with bonded β-cyclodextrin and acrylamide on functionalized silica gel for selective recognition of tryptophan in aqueous mediaJournal of Chromatography A, 2008
- Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MSJournal of Chromatography B, 2007
- Simultaneous determination of clozapine, clozapine N-oxide, N-desmethylclozapine, risperidone, and 9-hydroxyrisperidone in plasma by high performance liquid chromatography with ultraviolet detectionAnalytica Chimica Acta, 2002
- A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptorsInternational Clinical Psychopharmacology, 1995